Fujifilm Holdings Corp. said Friday it is on course to supply the anti-influenza drug Avigan for 2 million COVID-19 patients by next March, meeting a target set by the Japanese government to ramp up production of the potential treatment for the new coronavirus."We plan to complete delivery of the drug for 2 million people within fiscal 2020 to the government," said Fujifilm Senior Vice President Junji Okada in an online press conference on its earnings for the year ended March."The drug has received much interest from foreign countries," Okada said of Avigan, also known as favipiravir, that…READ FULL ARTICLE
